Prosecution Insights
Last updated: August 17, 2026

Examiner: CHATTIN, AMY MARIE

Tech Center 1600 • Art Units: 1637 1642 1643 1644 1646

This examiner grants 73% of resolved cases

Performance Statistics

72.9%
Allow Rate
+12.9% vs TC avg
87
Total Applications
+43.5%
Interview Lift
1397
Avg Prosecution Days
Based on 48 resolved cases, 2023–2026

Rejection Statute Breakdown

3.1%
§101 Eligibility
18.3%
§102 Novelty
33.9%
§103 Obviousness
32.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17927529 BISPECIFIC MOLECULES FOR SELECTIVELY MODULATING T CELLS Non-Final OA Dana-Farber Cancer Institute, Inc.
17773283 DEGRADATION OF SURFACE PROTEINS USING BISPECIFIC BINDING AGENT Non-Final OA The Regents of the University of California
18560746 CHIMERIC POLYPEPTIDES AND METHODS OF USE Non-Final OA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month